Regulatory affairs due diligence in EU

Challenge An established generics company looking to acquire the French rights of an existing product franchise needed to perform regulatory and clinical due diligence on the French dossier.
Learn More

Point of care diagnostics due diligence

Challenge A major European venture capital investor needed to analyze the business plan of a novel point-of-care diagnostics company.
Learn More

Development strategy and business support for an early-stage oncology company

Challenge After a seed investment, Evgen, a start-up biotech had built an IP portfolio in the field of glucosinolates, chemicals found in brassica vegetables, that are potent inducers of...
Learn More

Conducting IP due diligence

Challenge We have conducted multiple due diligence projects, below are three examples:
Learn More

Assessment of an AAV gene therapy for an ophthalmic indication

Challenge: Alacrita conducted an assessment of an AAV gene therapy for an ophthalmic indication, focusing on market potential, technical and regulatory issues and identification of key risks.
Learn More

Neuroscience Due Diligence

Alzheimer's due diligence Our client, a major pension fund, was considering an investment opportunity in a Phase III neuroscience company. The company was developing a small molecule to provide...
Learn More

Supporting due diligence on regulatory affairs

Challenge: A clinical stage biopharmaceutical specialist needed support with its regulatory due diligence activities for products in the respiratory field.
Learn More

Opportunity analysis - blood products

A life science venture capital fund was contemplating investing in advanced plasma product opportunities being developed by a biopharmaceutical company.  Alacrita was commissioned to provide a...
Learn More

Clinical strategy, medical oversight and clinical due diligence

Alacrita's consulting team supports a number of pharmaceutical & biotech companies with medical and clinical strategy. We have particular depth in oncology, but also have expertise in infectious...
Learn More

Due diligence on a diagnostics investment opportunity

Challenge: A major European venture capital investor needed help to review the business plan and competitive positioning of a novel point-of-care diagnostics company. The company was developing a...
Learn More

Intellectual Property Analysis & Strategy

Due diligence For a financial investor, Alacrita conducted an IP assessment on a late stage cell therapy  investment opportunity. The assessment revealed that the US and EPO patents relied on just...
Learn More

Pharmaceutical & Biotech Due Diligence

Alacrita is a leading provider of due diligence to the pharmaceutical industry. Its core team of partners, each of whom has industry experience, are supported by a team of expert, life science...
Learn More
Content not found